1.      Anhalt GJ. Paraneoplastic Pemphigus. Journal of Investigative Dermatology Symposium Proceedings. 2004;9(1):29-33.

2.      Baroni A, Puca R V., Aiello FS, et al. Cefuroxime-induced pemphigus erythematosus in a young boy. Clin Exp Dermatol. 2009;34(6):708-710.

3.      Bruckner-Tuderman L, Has C. Molecular Heterogeneity of Blistering Disorders: The Paradigm of Epidermolysis Bullosa. Journal of Investigative Dermatology. 2012;132:E2-E5. doi:10.1038/skinbio.2012.2

4.      Burgdorf WHC, Plewig G, Wolff HH, Landthaler M eds. Braun-Falco’s Dermatology. 4th ed. Springer; 2018.

5.      Chan LS, Ahmed AR, Anhalt GJ, et al. The First International Consensus on Mucous Membrane Pemphigoid. Arch Dermatol. 2002;138(3).

6.      Chimanovitch I, Hamm H, Georgi M, et al. Bullous Pemphigoid of Childhood. Arch Dermatol. 2000;136(4).

7.      Connelly EA, Aber C, Kleiner G, Nousari C, Charles C, Schachner LA. Generalized Erythrodermic Pemphigus Foliaceus in a Child and Its Successful Response to Rituximab Treatment. Pediatr Dermatol. 2007;24(2):172-176.

8.      Contestable JJ, Edhegard KD, Meyerle JH. Bullous Systemic Lupus Erythematosus: A Review and Update to Diagnosis and Treatment. Am J Clin Dermatol. 2014;15(6):517-524.

9.      Daneshpazhooh M, Moeineddin F, Kiani A, et al. Fatal Paraneoplastic Pemphigus After Removal of Castleman’s Disease in a Child. Pediatr Dermatol. 2012;29(5):656-657.

10.  Denyer JE. Wound Management for Children with Epidermolysis Bullosa. Dermatol Clin. 2010;28(2):257-264. doi:10.1016/j.det.2010.01.002

11.  Durdu M, Baba M, Seçkin D. The value of Tzanck smear test in diagnosis of erosive, vesicular, bullous, and pustular skin lesions. J Am Acad Dermatol. 2008;59(6):958-964.

12.  Egan CA, Mb , Mrcpi , Zone JJ. Linear IgA bullous dermatosis. Int J Dermatol. 1999;38(11):818-827.

13.  Fine JD, Bruckner-Tuderman L, Eady RAJ, et al. Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70(6):1103-1126. doi:10.1016/j.jaad.2014.01.903

14.  Fine JD. Epidemiology of Inherited Epidermolysis Bullosa Based on Incidence and Prevalence Estimates From the National Epidermolysis Bullosa Registry. JAMA Dermatol. 2016;152(11):1231. doi:10.1001/jamadermatol.2016.2473

15.  Friedman H, Campbell I, Rocha-Alvarez R, et al. Endemic pemphigus foliaceus (fogo selvagem) in Native Americans from Brazil. J Am Acad Dermatol. 1995;32(6):949-956.

16.  Fujimoto W, Hamada T, Yamada J, Matsuura H, Iwatsuki K. Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE. J Dermatol. 2005;32(12):1021-1027.

17.  Guide S V., Gonzalez ME, Bağcı IS, et al. Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa. New England Journal of Medicine. 2022;387(24):2211-2219. doi:10.1056/NEJMoa2206663

18.  Gupta MT, Jerajani HR. Control of childhood pemphigus erythematosus with steroids and azathioprine. British Journal of Dermatology. 2004;150(1):163-164.

19.  Gürcan H, Mabrouk D, Razzaque Ahmed A. Management of pemphigus in pediatric patients. Minerva Pediatr. 2011;63(4):279-291.

20.  Hamada T, Tsuruta D, Fukuda S, et al. How do keratinizing disorders and blistering disorders overlap? Exp Dermatol. 2013;22(2):83-87. doi:10.1111/exd.12021

21.  Hammers CM, Stanley JR. Patients with pemphigus foliaceus may retain antibody reactivity against calcium‐stabilized, distal desmoglein 1 domains in remission. British Journal of Dermatology. 2016;174(1):17-18.

22.  Has C, Bauer JW, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. British Journal of Dermatology. 2020;183(4):614-627. doi:10.1111/bjd.18921

23.  Has C, Fischer J. Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes. Exp Dermatol. 2019;28(10):1146-1152. doi:10.1111/exd.13668

24.  Has C, Kern JS. Collagen XVII. Dermatol Clin. 2010;28(1):61-66. doi:10.1016/j.det.2009.10.007

25.  Has C, Liu L, Bolling MC, et al. Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. Br J Dermatol. 2020;182(3):574-592. doi:10.1111/bjd.18128

26.  Hashimoto T, Yasumoto S, Nagata Y, Okamoto T, Fujita S. Clinical, histopathological and immunological distinction in two cases of IgA pemphigus. Clin Exp Dermatol. 2002;27(8):636-640.

27.  Jones SK, Schwab HP, Norris DA. Childhood Pemphigus Foliaceus: Case Report and Review of the Literature. Pediatr Dermatol. 1986;3(6):459-463.

28.  Khanna D, Bardhan A. Epidermolysis Bullosa.; 2025.

29.  Kharfi M, Khaled A, Anane R, Fazaa B, Kamoun MR. Early Onset Childhood Cicatricial Pemphigoid: A Case Report and Review of the Literature. Pediatr Dermatol. 2010;27(2):119-124.

30.  Kim S, Kim J, Kim Y. Epidermolysis Bullosa Acquisita: A Retrospective Clinical Analysis of 30 Cases. Acta Dermato Venereologica. 2011;91(3):307-312.

31.  Kong YL, Lim YL, Chandran NS. Retrospective Study on Autoimmune Blistering Disease in Paediatric Patients. Pediatr Dermatol. 2015;32(6):845-852.

32.  Lavallée A, Bourret-Massicotte D, Laughrea PA. Childhood Mucous Membrane Pemphigoid. Cornea. 2013;32(10):1399-1401.

33.  Leibowitz MR, Voss SP. Juvenile pemphigus foliaceous: response to dapsone. Arch Dermatol. 1993;129(7):910.

34.  Mabrouk D, Ahmed AR. Analysis of Current Therapy and Clinical Outcome in Childhood Pemphigus Vulgaris. Pediatr Dermatol. 2011;28(5):485-493.

35.  Mariath LM, Santin JT, Schuler-Faccini L, Kiszewski AE. Inherited epidermolysis bullosa: update on the clinical and genetic aspects. An Bras Dermatol. 2020;95(5):551-569. doi:10.1016/j.abd.2020.05.001

36.  Marsden RA, McKee PH, Bhogal B, Black MM, Kennedy LA. A study of benign chronic bullous dermatosis of childhood and comparison with dermatitis herpetiformis and bullous pemphigoid occurring in childhood. Clin Exp Dermatol. 1980;5(2):159-172.

37.  Mellerio JE, Robertson SJ, Bernardis C, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. British Journal of Dermatology. 2016;174(1):56-67. doi:10.1111/bjd.14104

38.  Metin A, Özcan H, Alp S, eds. Kelebek Hastalığı (Epidermolizis Bülloza). 8th ed. Türk Dermatoloji Derneği Yayınları

39.  Mintz EM, Morel KD. Clinical Features, Diagnosis, and Pathogenesis of Chronic Bullous Disease of Childhood. Dermatol Clin. 2011;29(3):459-462.

40.  Mostafa MI, Hassıb NF, Nemat AH. Oral mucous membrane pemphigoid in a 6‐year‐old boy: diagnosis, treatment and 4 years follow‐up. Int J Paediatr Dent. 2010;20(1):76-79.

41.  Natsuga K. Plectin-related skin diseases. J Dermatol Sci. 2015;77(3):139-145. doi:10.1016/j.jdermsci.2014.11.005

42.  Navedo de las Heras M. Linear IgA bullous dermatosis of childhood: good response to antibiotic treatment. Clin Exp Dermatol. 2014;39(3):395-397.

43.  Pasmooij AMG, Pas HH, Jansen GHL, Lemmink HH, Jonkman MF. Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands. British Journal of Dermatology. 2007;156(5):861-870. doi:10.1111/j.1365-2133.2006.07730.x

44.  Pourani MR, Vahidnezhad H, Mansouri P, et al. Losartan treatment improves recessive dystrophic epidermolysis bullosa: A case series. Dermatol Ther. 2022;35(7). doi:10.1111/dth.15515

45.  Rao R, Shetty VM. Utility of Immunofluorescence Antigen Mapping in Hereditary Epidermolysis Bullosa. Indian J Dermatol. 2021;66(4):360-365. doi:10.4103/ijd.IJD_131_20

46.  Reunala T, Kosnai I, Karpati S, Kuitunen P, Torok E, Savilahti E. Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet. Arch Dis Child. 1984;59(6):517-522.

47.  Reunala T, Salmi TT, Hervonen K, et al. IgA antiepidermal transglutaminase antibodies in dermatitis herpetiformis: a significant but not complete response to a gluten-free diet treatment. British Journal of Dermatology. 2015;172(4):1139-1141.

48.  Richter BJ, McNutt NS. The spectrum of epidermolysis bullosa acquisita. Arch Dermatol. 1979;115(11):1325-1328.

49.  Robertson SJ, Orrin E, Lakhan MK, et al. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study. Acta Derm Venereol. 2021;101(8):adv00523. doi:10.2340/00015555-3875

50.  Roenigk HH. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol. 1971;103(1):1-10.

51.  Rose C, Armbruster FP, Ruppert J, Igl BW, Zillikens D, Shimanovich I. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. J Am Acad Dermatol. 2009;61(1):39-43.

52.  Sadler E, Schafleitner B, Lanschuetzer C, et al. Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab. British Journal of Dermatology. 2007;157(2):417-419.

53.  Salmi TT, Hervonen K, Kurppa K, Collin P, Kaukinen K, Reunala T. Celiac disease evolving into dermatitis herpetiformis in patients adhering to normal or gluten-free diet. Scand J Gastroenterol. 2015;50(4):387-392.

54.  Sansaricq F, Stein SL, Petronic-Rosic V. Autoimmune bullous diseases in childhood. Clin Dermatol. 2012;30(1):114-127.

55.  Schwieger-Briel A, Moellmann C, Mattulat B, et al. Bullous pemphigoid in infants: characteristics, diagnosis and treatment. Orphanet J Rare Dis. 2014;9:185.

56.  Stanley JR, Amagai M. Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome. New England Journal of Medicine. 2006;355(17):1800-1810.

57.  Tang JY, Marinkovich MP, Lucas E, et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2021;16(1):175. doi:10.1186/s13023-021-01811-7

58.  Templet JT, Welsh JP, Cusack CA. Childhood dermatitis herpetiformis: a case report and review of the literature. Cutis. 2007;80(6):473-476.

59.  Templet JT, Welsh JP, Cusack CA. Childhood dermatitis herpetiformis: a case report and review of the literature. Cutis. 2007;80(6):473-476.

60.  Vinay K, Kanwar AJ, Sawatkar GU, Dogra S, Ishii N, Hashimoto T. Successful use of rituximab in the treatment of childhood and juvenile pemphigus. J Am Acad Dermatol. 2014;71(4):669-675.

61.  Waisbourd-Zinman O, Ben-Amitai D, Cohen AD, et al. Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics. J Am Acad Dermatol. 2008;58(1):41-48.

62.  Waschke J. The desmosome and pemphigus. Histochem Cell Biol. 2008;130(1):21-54.

63.  Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. J Am Acad Dermatol. 1988;19(5):792-805.

64.  Yazganoğlu KD, Baykal C, Kücükoglu R. Childhood pemphigus vulgaris: five cases in 16 years. J Dermatol. 2006;33(12):846-849.

65.  Youssefian L, Vahidnezhad H, Uitto J. Kindler Syndrome.; 2022.